These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26367809)

  • 1. Usefulness of Interferon-gamma Release Assays in the Screening of Latent Tuberculosis Infection in Immigrant and Internationally Adopted Children.
    Méndez-Echevarría A; Sainz T; García-Hortelano M; Baquero-Artigao F; Mellado MJ
    Pediatr Infect Dis J; 2015 Oct; 34(10):1141-2. PubMed ID: 26367809
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculin skin testing and T-SPOT.TB in internationally adopted children.
    Spicer KB; Turner J; Wang SH; Koranyi K; Powell DA
    Pediatr Infect Dis J; 2015 Jun; 34(6):599-603. PubMed ID: 25973937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Latent Tuberculosis Infection.
    Lardizabal AA; Reichman LB
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays.
    Wei Z; Yang M; Quan B; Wang Y; Wu Y; Ji B
    J Hosp Infect; 2013 Aug; 84(4):323-5. PubMed ID: 23806839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End TB Strategy: Time to Move on From the Skin Test to the Interferon-
    Kruse M; Cruikshank W
    Am J Public Health; 2019 Aug; 109(8):1102-1104. PubMed ID: 31268768
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?
    Banaei N; Gaur RL; Pai M
    J Clin Microbiol; 2016 Apr; 54(4):845-50. PubMed ID: 26763969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing International Adoptees for Tuberculosis.
    Priya Dhar C; Elena Gonzalez B; Dragga T; Bothe D; Mandalakas AM
    Pediatr Infect Dis J; 2015 Oct; 34(10):1138-9. PubMed ID: 26367807
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculin skin test and/or interferon gamma release assay: is it still time to debate?
    Sanduzzi A; Marchetiello I; Bocchino M; Boccia G; De Caro F
    Infez Med; 2017 Mar; 25(1):80-81. PubMed ID: 28353462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact tracing in low-incidence tuberculosis settings.
    van Leth F; Borgdorff M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1566. PubMed ID: 22118163
    [No Abstract]   [Full Text] [Related]  

  • 11. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immigration screening for latent tuberculosis infection.
    Denholm JT
    Med J Aust; 2013 Jun; 198(10):524. PubMed ID: 23725254
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
    Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
    Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis diagnostics in active and latent disease.
    Stevenson DR; Corrah T
    Br J Hosp Med (Lond); 2018 Jun; 79(6):C82-C85. PubMed ID: 29894245
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.
    Reves R; Daley CL
    JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in the diagnosis of latent tuberculosis infection.
    Schluger NW
    Semin Respir Crit Care Med; 2013 Feb; 34(1):60-6. PubMed ID: 23460006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon-gamma release assays for hospital-based tuberculosis diagnostics in children and adolescents--a retrospective analysis].
    Knappik M; Schönfeld N; Günther A; Bergmann T; Magdorf K; Rüssmann H; Mauch H; Barker M
    Pneumologie; 2012 Apr; 66(4):207-11. PubMed ID: 22477480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study.
    Roth DZ; Ronald LA; Ling D; Chiang LY; Cook VJ; Morshed MG; Johnston JC
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331032
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of interferon-gamma release assays to calculate the annual risk of tuberculosis infection.
    Díez N; Giner E; Latorre I; Lacoma A; Roig FJ; Mialdea I; Díaz J; Serra-Vidal M; Escribano A; Domínguez J
    Pediatr Infect Dis J; 2015 Feb; 34(2):219-21. PubMed ID: 25144799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.